PROSPECTS AND OPPORTUNITIES
Stronger growth opportunities for analgesics over the forecast period
Analgesics is expected to continue witnessing high and rising demand over the forecast period, due to the continuous spread of illnesses and chronic diseases in Saudi Arabia. Demand will be also supported by greater health awareness, longer life expectancy, the expanding population, and a rising number of visitors to the Kingdom.
Localising the pharmaceutical industry
As per the Vision 2030 initiative, the country aims to localise various industries including the pharmaceutical sector. This is to enhance the Kingdom's self-sufficiency in producing essential medicines and reduce its reliance on imported pharmaceutical products, thereby supporting local producers.
Pharmacies set to remain dominant distribution channels
Pharmacies is expected to remain the dominant distribution channel for analgesics in Saudi Arabia over the forecast period, benefiting from a large number of stores, ongoing promotional campaigns, loyalty programmes, and e-commerce websites/mobile apps. In addition, operators of pharmacies are set to continue to add new products to their private label portfolios.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Saudi Arabia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Saudi Arabia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Saudi Arabia report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Saudi Arabia?
- Which are the leading brands in Analgesics in Saudi Arabia?
- How are products distributed in Analgesics in Saudi Arabia?
- How has the regulatory and operating environment for Analgesics changed in Saudi Arabia?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Analgesics in Saudi Arabia - Category analysis
KEY DATA FINDINGS
Further price increases for analgesics but demand remains stable
Tabuk launches Migrotan to address symptoms of migraine
GSK Consumer Healthcare strengthens leadership of analgesics
Stronger growth opportunities for analgesics over the forecast period
Localising the pharmaceutical industry
Pharmacies set to remain dominant distribution channels
Consumer Health in Saudi Arabia - Industry Overview
Consumer health in 2024: The big picture
2024 key trends
Competitive landscape
Retailing developments
What next for consumer health?
OTC Registration And Classification
Vitamins And Dietary Supplements Registration And Classification
Self-medication/self-care And Preventive Medicine
Switches
DISCLAIMER
DEFINITIONS
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!